Floatz logo

ETHAMBUTOL

Tuberculosis

Texas Tech University Health Sciences CenterSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Tuberculosis cohort.

Asset / SponsorPhaseRating
SULFAMETHOXAZOLE
Texas Tech University Health Sciences Center
Phase 4BB
Trimethoprim
Texas Tech University Health Sciences Center
Phase 4BB
Dapsone
Texas Tech University Health Sciences Center
Phase 4BB
Selenium
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3BB
Folic Acid
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3BB

View all 13 →

Same molecule, other indications

ETHAMBUTOL is also rated in:

Mycobacterium avium complex diseaseDormant
B
Indicative ·
57 / 100
View asset →
obesity disorderDormant
B
Indicative ·
56 / 100
View asset →
pulmonary non-tuberculous mycobacterial infectionDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →